Cordarone, Pacerone, Amiodarone News

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed cardiologists identify a therapy's effect on mortality as the attribute that most influences their prescribing decisions in maintenance of normal sinus rhythm in atrial fibrillation.

Q: I am a singer, so my voice is critical to both my livelihood and my sense of well-being. I was recently diagnosed with mild asthma, and my doctor prescribed an inhaler called Flovent.

The Food and Drug Administration says an experimental drug from Sanofi-Aventis could significantly decrease hospitalizations caused by irregular heart rhythms.

* The FDA is reminding practitioners that concurrent use of simvastatin and the antiarrhythmic drug amiodarone can increase the risk of rhabdomyolysis, a rare but possibly fatal muscle disease.

A Reno federal judge hearing a wrongful death case against a pharmaceutical company Tuesday set what one lawyer called "a dangerous precedent" by saying that state laws and the federal privacy act do not ...

Clopidogrel bisulfate January 26, 2009 Healthcare providers should continue to prescribe and patients should continue to take clopidogrel as directed, because... Topical Anesthetics January 16, 2009 Audience: ...

Excessive drinking offers no benefits whatsoever, but having a single glass of red wine each day could help the heart, the U.S. Library of Medicine says.

The U.S. Food and Drug Administration has approved Riastap to treat a blood disorder caused by a rare genetic condition.

Epiduo Epiduo Gel is a once-daily, topical acne treatment that combines the well-tolerated retinoid adapalene, and benzoyl peroxide, a well-known antimicrobial.

CyDex Pharmaceuticals, Inc. today announced that Prism Pharmaceuticals' NEXTERONE , which recently received new drug application approval from the U.S. Food and Drug Administration , is based on the ...

The U.S. Department of Agriculture suggests that you budget calories the way you do money -- in general, don't use more than you need.

The approval triggers a second USD 10 million milestone payment from Paul Capital.

NEXTERONE is indicated for the treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy.